{"id":"NCT01530243","sponsor":"Urmia University of Medical Sciences","briefTitle":"The Effect of Terazosin and Tolterodine on Ureteral Stent Related Symptoms","officialTitle":"Phase One of Study on Urinary Stent Complications and Treatment","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2012-01","primaryCompletion":"2012-08","completion":"2012-09","firstPosted":"2012-02-09","resultsPosted":"2015-03-02","lastUpdate":"2015-03-02"},"enrollment":104,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Disorder of Urinary Stent"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":["Group 1"]},{"type":"DRUG","name":"Terazosine","otherNames":["Group 2"]},{"type":"DRUG","name":"Tolterodine","otherNames":["Group 3"]},{"type":"DRUG","name":"Tolterodine + Terazosin","otherNames":["Group 4"]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Terazosin","type":"ACTIVE_COMPARATOR"},{"label":"Tolterodine","type":"ACTIVE_COMPARATOR"},{"label":"Tolterodine + Terazosin","type":"ACTIVE_COMPARATOR"}],"summary":"The aim of the investigators study is to evaluate whether alpha-blockers such as terazosin and anti-cholinergics such as tolterodine can be relieve the DJ-stent related symptoms.","primaryOutcome":{"measure":"Lower Urinary Tract Symptoms (LUTS)","timeFrame":"Expected average of 2 weeks","effectByArm":[{"arm":"Placebo","deltaMin":11.12,"sd":7.84},{"arm":"Terazosin","deltaMin":4.39,"sd":6.03},{"arm":"Tolterodine","deltaMin":7.21,"sd":6.57},{"arm":"Tolterodine + Terazosin","deltaMin":5.58,"sd":4.82}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["Iran"]},"refs":{"pmids":["24456787"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":24},"commonTop":[]}}